Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Pediatric Gastroenterology

Feeding, Growth, and Digestive Health in CFC3

At a Glance

Children with CFC3 commonly have feeding and digestive problems that can affect safety, nutrition, and growth. Early assessment by a multidisciplinary team can guide tube feeding, reflux care, constipation treatment, and sick-day planning.

Feeding and digestion are among the most significant daily challenges for families living with Cardiofaciocutaneous Syndrome 3 (CFC3). It is estimated that the vast majority (90% to 100% in mixed CFC cohorts) of children face severe feeding difficulties [1][2]. It is vital to understand that these challenges are a core biological feature of the syndrome and are not a reflection of your parenting or efforts.

The Spectrum of Feeding Challenges

In CFC3, the MAP2K1 mutation can affect the muscles and nerves involved in the complex process of eating and digesting. These issues often begin within hours of birth and can persist throughout childhood [3][4].

  • Oral-Motor Dysfunction: Many infants have a weak or uncoordinated suck-and-swallow reflex. This can make feeding exhausting and potentially unsafe if the child aspirates (breathes food or liquid into the lungs) [3][5]. If a clinical assessment suggests aspiration, a specialized test called a Videofluoroscopic Swallow Study (VFSS) may be ordered to watch how food travels down the throat.
  • Severe Reflux and Vomiting: Gastroesophageal reflux is extremely common. However, persistent, forceful, bilious (green), or bloody vomiting is not just reflux—it requires standard urgent pediatric evaluation to rule out rare structural issues reported in some cases, such as pyloric stenosis (a narrowing of the stomach exit) or intestinal malrotation [1][6].
  • Food Selectivity: As children grow, they may develop intense aversions to certain textures or tastes.

The Role of Enteral Nutrition (Feeding Tubes)

Because of the high risk of malnutrition and growth failure, many children with CFC3 require enteral nutrition—receiving liquid nutrition directly into the stomach or intestines [1][3].

  • NG-Tubes vs. G-Tubes: A nasogastric (NG) tube is often used for short-term support. However, for long-term management, a gastrostomy tube (G-tube) placed into the stomach is frequently recommended to ensure safe calorie delivery [3].
  • Dual Benefits: Tube feeding takes the stress out of mealtimes and supports safe physical growth. Importantly, it does not mean your child must stop eating by mouth; if oral feeding is deemed safe, oral skills development can continue alongside tube feeding.

Hypoglycemia During Illness

A rare but serious complication reported in children with severe feeding issues and CFC is nonketotic hypoglycemia—low blood sugar that occurs without the normal protective production of ketones [7]. This vulnerability is highest when a child is ill, vomiting, or fasting for too long.

  • Sick-Day Protocol: Families must have a written sick-day plan provided by an endocrinologist or metabolic specialist. This plan will detail how to check glucose (if appropriate), what safe fluids to give, and when to seek emergency care [7].
  • Emergency Rules: Never give food or liquid by mouth to a child who is drowsy, seizing, or unable to swallow safely. If your child shows altered consciousness or extreme lethargy, call local emergency services immediately.

Managing Gastrointestinal Health

Beyond feeding, the entire digestive tract may be affected by dysmotility—where the muscles of the GI tract do not move food through efficiently [1].

  • Constipation: This is a frequent issue that requires proactive management with fiber, fluids, or stool softeners to prevent discomfort and “backup” that can worsen reflux [1][8].

Proactive Care Team: Successful management requires a multidisciplinary group. This usually includes a pediatric gastroenterologist, a registered dietitian, and a speech-language pathologist or feeding therapist [1][3].

Common questions in this guide

Why do children with CFC3 often have feeding problems?
CFC3 can affect the muscles and nerves needed for sucking, swallowing, and digestion. Many infants have weak or poorly coordinated feeding, reflux, vomiting, or food selectivity, and these difficulties may begin soon after birth and continue through childhood.
When might a child with CFC3 need a feeding tube?
A feeding tube may be recommended when oral feeding is unsafe, too tiring, or not providing enough calories for growth. An NG tube is often used for short-term support, while a G-tube may be better for long-term nutrition. If oral feeding is safe, children may continue practicing eating by mouth alongside tube feeding.
What is a VFSS, and when is it used in CFC3?
A videofluoroscopic swallow study, or VFSS, uses imaging to watch food or liquid move through the throat during swallowing. A clinician may recommend it when there are signs of aspiration, such as coughing during feeds, or concern that food or liquid is entering the lungs without obvious symptoms.
What should I do if my child with CFC3 is vomiting or refusing food during an illness?
Families should follow a written sick-day plan from their child’s endocrinologist or metabolic specialist, including instructions for fluids, glucose checks when appropriate, and when to seek emergency care. Never give food or liquid by mouth to a child who is drowsy, having a seizure, or unable to swallow safely; call emergency services for altered consciousness or extreme lethargy.
When is vomiting in a child with CFC3 more than ordinary reflux?
Persistent, forceful, green or bilious, or bloody vomiting needs urgent pediatric evaluation rather than being assumed to be reflux. The medical team may assess for uncommon structural problems such as pyloric stenosis or intestinal malrotation.
How can constipation and digestive slowing be managed in CFC3?
CFC3-related digestive slowing can contribute to constipation and may worsen discomfort or reflux. A child’s care team may recommend a plan involving appropriate fiber, fluids, or stool softeners, with guidance from a pediatric gastroenterologist or dietitian.

Get notified when new evidence is published on cardiofaciocutaneous syndrome 3.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Management of nutritional and gastrointestinal issues in RASopathies: A narrative review.

    Onesimo R, Giorgio V, Viscogliosi G, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(4)):478-493 doi:10.1002/ajmg.c.32019.

    PMID: 36515923
  2. 2

    Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients.

    Feng B, Li X, Zhang Q, et al.

    Orphanet journal of rare diseases 2023; (18(1)):284 doi:10.1186/s13023-023-02878-0.

    PMID: 37697378
  3. 3

    Case report: Gastroenterological management in a case of cardio-facio-cutaneous syndrome.

    Ciacchini B, Di Nardo G, Marin M, et al.

    Frontiers in pediatrics 2023; (11()):1160147 doi:10.3389/fped.2023.1160147.

    PMID: 37138575
  4. 4

    The "FEEDS (FEeding Eating Deglutition Skills)" over Time Study in Cardiofaciocutaneous Syndrome.

    Onesimo R, Sforza E, Giorgio V, et al.

    Genes 2023; (14(7)) doi:10.3390/genes14071338.

    PMID: 37510243
  5. 5

    Phoniatric, Audiological, Orodental and Speech Problems in a Boy with Cardio-Facio-Cutaneous Syndrome Type 3 (CFC 3) Due to a Pathogenic Variant in MAP2K1 - Case Study.

    Kosztyła-Hojna B, Borys J, Zdrojkowski M, et al.

    The application of clinical genetics 2021; (14()):389-398 doi:10.2147/TACG.S316215.

    PMID: 34522120
  6. 6

    Cardio-facio-cutaneous syndrome and gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP 2 K2 gene.

    Serra G, Felice S, Antona V, et al.

    Italian journal of pediatrics 2022; (48(1)):65 doi:10.1186/s13052-022-01241-6.

    PMID: 35509048
  7. 7

    Severe neuroglycopenic symptoms due to nonketotic hypoglycemia in children with cardio-facio-cutaneous syndrome.

    Shiohama T, Fujii K, Kosaki R, et al.

    American journal of medical genetics. Part A 2022; (188(12)):3505-3509 doi:10.1002/ajmg.a.62926.

    PMID: 35943247
  8. 8

    Prevalence of gastrointestinal disorders in individuals with RASopathies: May RAS/MAP/ERK pathway dysfunctions be a model of neuropathic pain and visceral hypersensitivity?

    Leoni C, Giorgio V, Stella G, et al.

    American journal of medical genetics. Part A 2022; (188(11)):3287-3293 doi:10.1002/ajmg.a.62917.

    PMID: 35894438

This page offers general information about feeding, growth, and digestive concerns in children with CFC3; it is not medical advice. Ask your child’s care team for an individualized feeding, sick-day, and emergency plan.